Immunome Inc IMNM:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/30/22 EDT
3.21quote price arrow up+0.59 (+22.52%)
Volume
496,557
52 week range
2.09 - 27.80
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.21
  • 52 Week High27.80
  • 52 Week High Date09/24/21
  • 52 Week Low2.09
  • 52 Week Low Date05/11/22

Key Stats

  • Market Cap38.94M
  • Shares Out12.13M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-75.23

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.21
  • 52 Week High27.80
  • 52 Week High Date09/24/21
  • 52 Week Low2.09
  • 52 Week Low Date05/11/22
  • Market Cap38.94M
  • Shares Out12.13M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-75.23

RATIOS/PROFITABILITY

  • EPS (TTM)-2.71
  • P/E (TTM)-1.18
  • Fwd P/E (NTM)-1.45
  • EBITDA (TTM)-32.271M
  • ROE (TTM)-85.71%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/17/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Immunome Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Immunome, Inc. is a biopharmaceutical company utilizing its human memory B cell platform to discover and develop antibody therapeutics. The Company's primary focus areas are oncology and infectious diseases. Its discovery platform identifies therapeutic antibodies and their targets by leveraging components of the immune system, memory B cells, from patients who have learned to fight off their disease. Its lead discovery programs include IMM-ONC-01 and IMM-BCP-01. The...
Michael Rapp
Independent Chairman of the Board
Purnanand Sarma Ph.D.
President, Chief Executive Officer, Director
Corleen Roche
Chief Financial Officer
Sandra Stoneman
Chief Legal Officer, General Counsel, Company Secretary
Address
665 STOCKTON DRIVE, SUITE 300
Exton, PA
19341
United States